Diagnostic Approach to Active Hemolysis with Intestinal Inflammation

Critical Diagnostic Steps

The American College of Physicians recommends obtaining a peripheral blood smear and direct Coombs test to differentiate immune-mediated hemolysis from non-immune mechanical hemolysis, as this distinction fundamentally changes management from corticosteroids to potential complement inhibition or plasma exchange 1, 2, 3
The presence of schistocytes in a peripheral blood smear indicates microangiopathic hemolytic anemia and suggests thrombotic microangiopathy rather than autoimmune causes, according to the American Society of Hematology 1, 3
A positive Coombs test confirms immune-mediated hemolysis and warrants corticosteroid therapy, as recommended by the American College of Rheumatology 2
A negative Coombs test with schistocytes strongly suggests atypical hemolytic uremic syndrome or other thrombotic microangiopathy, particularly given the intestinal inflammation, as stated by the National Institute of Diabetes and Digestive and Kidney Diseases 1, 3

The triad of non-immune hemolytic anemia, thrombocytopenia, and renal involvement defines atypical hemolytic uremic syndrome, according to the European Renal Association 1
Thrombocytopenia is required for aHUS diagnosis, with a platelet count of less than 150,000/mm³ or a 25% reduction, as recommended by the International Society of Nephrology 1
Measuring ADAMTS13 activity urgently is necessary to exclude thrombotic thrombocytopenic purpura, with severely deficient activity indicating TTP, not aHUS, as stated by the American Society of Hematology 1

The American College of Gastroenterology recommends pursuing a complete autoimmune panel, including ANA, rheumatoid factor, and HLA-B27, to identify systemic autoimmune disease 2
Complement levels and genetic testing for complement pathway mutations are necessary if aHUS is suspected, as recommended by the National Institute of Allergy and Infectious Diseases 1

If the Coombs test is positive, the American College of Rheumatology recommends starting prednisone 1-2 mg/kg/day orally as first-line therapy for autoimmune hemolytic anemia 2
If the Coombs test is negative, the American Society of Nephrology recommends urgent complement inhibition therapy, such as eculizumab, for atypical hemolytic uremic syndrome 1

The American College of Physicians recommends asking specifically about systemic symptoms, including rashes, photosensitivity, oral ulcers, joint pain, and morning stiffness, to identify underlying systemic autoimmune disease 2
Neurological symptoms, seizures, and vision changes should be assessed, as 10-20% of aHUS patients have neurological involvement, according to the National Institute of Neurological Disorders and Stroke 1, 2